We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$918M
AUM Growth
-$131M
Cap. Flow
-$175M
Cap. Flow %
-19.06%
Top 10 Hldgs %
16.38%
Holding
1,902
New
267
Increased
673
Reduced
501
Closed
283

Sector Composition

Rank Sector Weight
1 Financials 15.47%
2 Technology 14.63%
3 Healthcare 10.78%
4 Consumer Discretionary 10.41%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVAX icon
1326
Novavax
NVAX
$1.27B
$4K ﹤0.01%
164
-60
-27% -$1.34K
NWFL icon
1327
Norwood Financial Corp
NWFL
$370M
$4K ﹤0.01%
+146
New +$4.21K
PKBK icon
1328
Parke Bancorp
PKBK
$402M
$4K ﹤0.01%
+196
New +$3.29K
PLCE icon
1329
Children's Place
PLCE
$58.9M
$4K ﹤0.01%
37
-1,751
-98% -$188K
SD icon
1330
SandRidge Energy
SD
$496M
$4K ﹤0.01%
+202
New +$3.75K
SGMO
1331
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4K ﹤0.01%
283
-309
-52% -$3.42K
DCOY
1332
Decoy Therapeutics
DCOY
$2.16M
0
TLYS icon
1333
Tilly's
TLYS
$126M
$4K ﹤0.01%
+335
New +$3.49K
TREX icon
1334
Trex
TREX
$4.93B
$4K ﹤0.01%
+160
New +$3.05K
TTMI icon
1335
TTM Technologies
TTMI
$14.2B
$4K ﹤0.01%
290
-3,112
-91% -$48.5K
TTNP
1336
DELISTED
Titan Pharmaceuticals
TTNP
$4K ﹤0.01%
1
AE
1337
DELISTED
Adams Resources & Energy Inc
AE
$4K ﹤0.01%
+85
New +$3.19K
INFI
1338
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$4K ﹤0.01%
2,638
+1,448
+122% +$1.8K
NOVN
1339
DELISTED
Novan, Inc. Common Stock
NOVN
$4K ﹤0.01%
63
+46
+271% +$2.19K
ABMD
1340
DELISTED
Abiomed Inc
ABMD
$4K ﹤0.01%
+21
New +$3.17K
CTT
1341
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$4K ﹤0.01%
+317
New +$3.69K
DSPG
1342
DELISTED
DSP Group Inc
DSPG
$4K ﹤0.01%
321
+31
+11% +$374
BSTC
1343
DELISTED
BioSpecifics Technologies Corp.
BSTC
$4K ﹤0.01%
81
QHC
1344
DELISTED
Quorum Health Corporation
QHC
$4K ﹤0.01%
744
+475
+177% +$1.93K
AKS
1345
DELISTED
AK Steel Holding Corp
AKS
$4K ﹤0.01%
772
+395
+105% +$2.26K
GNMX
1346
DELISTED
Aevi Genomic Medicine Inc
GNMX
$4K ﹤0.01%
2,856
+1,415
+98% +$1.81K
ACHN
1347
DELISTED
Achillion Pharmaceuticals
ACHN
$4K ﹤0.01%
934
-994
-52% -$4.41K
VSI
1348
DELISTED
Vitamin Shoppe Inc.
VSI
$4K ﹤0.01%
696
-152
-18% -$1.17K
CBM
1349
DELISTED
Cambrex Corporation
CBM
$4K ﹤0.01%
65
-46
-41% -$2.53K
LOXO
1350
DELISTED
Loxo Oncology, Inc
LOXO
$4K ﹤0.01%
42
-25
-37% -$1.94K

Similar funds

Meeder Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Meeder Asset Management held 1,902 positions worth $918M, down 12% from $1.05B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Meeder Asset Management withdrew a net $175M in Q3 2017, closing 283 positions and reducing 501 holdings. Its most notable exit was Altria Group, an estimated $4.49M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Meeder Asset Management opened a new position in RTX Corp worth $2.6M.

  • Meeder Asset Management's largest Q3 2017 buy was RTX Corp: 35,540 shares worth $2.6M.
  • Meeder Asset Management added most to Bank of New York Mellon in Q3 2017, an estimated $5.83M increase.
  • Meeder Asset Management's biggest Q3 2017 reduction was iShares JPMorgan USD Emerging Markets Bond ETF, cutting an estimated $46.1M.
  • Meeder Asset Management fully exited Altria Group in Q3 2017, selling an estimated $4.49M.
  • Meeder Asset Management's ten largest holdings make up 16% of its $918M portfolio in Q3 2017.
  • Meeder Asset Management opened 267 new positions and closed 283 in Q3 2017.
  • Meeder Asset Management's portfolio value fell 12% quarter-over-quarter to $918M.

Based on Meeder Asset Management's 13F filing for Q3 2017, filed 20 Oct 2017.